Profil
Bruce P.
Connop is an Independent Director at IBEX Technologies, Inc. since 2017.
He is also the Vice President-Preclinical Research & Development at Active Pass Pharmaceuticals, Inc. since 1999.
Previously, he worked as the VP-Non Clinical & Pharmaceutical Development at Transition Therapeutics, Inc. from 2006 to 2012.
Dr. Connop holds a doctorate degree from Queen's University.
Postes actifs de Bruce P. Connop
| Sociétés | Poste | Début |
|---|---|---|
| IBEX TECHNOLOGIES | Directeur/Membre du Conseil | 11/10/2017 |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Directeur Technique/Scientifique/R&D | 01/01/1999 |
Anciens postes connus de Bruce P. Connop
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Corporate Officer/Principal | - |
Formation de Bruce P. Connop
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Transition Therapeutics, Inc.
Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
IBEX Technologies, Inc.
IBEX Technologies, Inc. Pharmaceuticals: OtherHealth Technology Produces proprietary enzymes and reagents for diagnostic tests | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Health Technology |
















